APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Enalapril

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Enalapril Market Outlook and Growth Opportunities 2026

Report ID 173988070431 December 2025202 pages

Choose your research edition.

Industry ResearchEnalapril Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Enalapril Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Enalapril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enalapril Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Enalapril Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Enalapril market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Enalapril market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Enalapril market include Wockhardt Americas Inc, Watson Laboratories Inc, Teva Pharmaceuticals Usa Inc, Teva Parenteral Medicines Inc, Taro Pharmaceutical Industries Ltd, Sandoz Inc, Ranbaxy Laboratories Ltd, Mylan Pharmaceuticals Inc and Lek Pharmaceuticals D D, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enalapril market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enalapril and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enalapril sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enalapril market size, projected growth trends, production technologies, key applications, and end-use industries.

Enalapril Segment by Company

Wockhardt Americas Inc

Watson Laboratories Inc

Teva Pharmaceuticals Usa Inc

Teva Parenteral Medicines Inc

Taro Pharmaceutical Industries Ltd

Sandoz Inc

Ranbaxy Laboratories Ltd

Mylan Pharmaceuticals Inc

Lek Pharmaceuticals D D

Krka Dd Novo Mesto

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa

Hospira Inc

Hikma Farmaceutica (Portugal) Sa

Biovail Laboratories International Srl

Bedford Laboratories Div Ben Venue Laboratories Inc

Apothecon Inc Div Bristol Myers Squibb

Apotex Inc

Enalapril Segment by Type

10mg

2.5mg

20mg

5mg

Enalapril Segment by Application

Hospital

Drugs Store

Enalapril Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Enalapril status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Enalapril market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enalapril significant trends, drivers, influence factors in global and regions.

6. To analyze Enalapril competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enalapril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enalapril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enalapril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enalapril market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enalapril industry.

Chapter 3: Detailed analysis of Enalapril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Enalapril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Enalapril in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enalapril Industry Trends Table 2. Enalapril Industry Drivers Table 3. Enalapril Industry Opportunities and Challenges Table 4. Enalapril Industry Restraints Table 5. Global Enalapril Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enalapril Revenue Share by Company (2021-2026) Table 7. Global Enalapril Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Enalapril Sales Volume Share by Company (2021-2026) Table 9. Global Enalapril Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Enalapril Company Ranking, (2024-2026) & (USD Million) Table 11. Global Enalapril Key Company Manufacturing Base & Headquarters Table 12. Global Enalapril Company, Product Type & Application Table 13. Global Enalapril Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Enalapril by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg Table 18. Significant Companies of 2.5mg Table 19. Significant Companies of 20mg Table 20. Significant Companies of 5mg Table 21. Global Enalapril Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Enalapril Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Enalapril Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Enalapril Sales Volume Share by Type (2021-2026) Table 25. Global Enalapril Sales Volume Share by Type (2027-2032) Table 26. Global Enalapril Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Enalapril Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Enalapril Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Enalapril Sales Value Share by Type (2021-2026) Table 30. Global Enalapril Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Drugs Store Table 33. Global Enalapril Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Enalapril Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Enalapril Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Enalapril Sales Volume Share by Application (2021-2026) Table 37. Global Enalapril Sales Volume Share by Application (2027-2032) Table 38. Global Enalapril Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Enalapril Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Enalapril Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Enalapril Sales Value Share by Application (2021-2026) Table 42. Global Enalapril Sales Value Share by Application (2027-2032) Table 43. Global Enalapril Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Enalapril Sales by Region (2021-2026) & (K Units) Table 45. Global Enalapril Sales Market Share by Region (2021-2026) Table 46. Global Enalapril Sales by Region (2027-2032) & (K Units) Table 47. Global Enalapril Sales Market Share by Region (2027-2032) Table 48. Global Enalapril Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Enalapril Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Enalapril Sales Value Share by Region (2021-2026) Table 51. Global Enalapril Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Enalapril Sales Value Share by Region (2027-2032) Table 53. Global Enalapril Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Enalapril Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Enalapril Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Enalapril Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Enalapril Sales by Country (2021-2026) & (K Units) Table 58. Global Enalapril Sales Market Share by Country (2021-2026) Table 59. Global Enalapril Sales by Country (2027-2032) & (K Units) Table 60. Global Enalapril Sales Market Share by Country (2027-2032) Table 61. Global Enalapril Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Enalapril Sales Value Market Share by Country (2021-2026) Table 63. Global Enalapril Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Enalapril Sales Value Market Share by Country (2027-2032) Table 65. Wockhardt Americas Inc Company Information Table 66. Wockhardt Americas Inc Business Overview Table 67. Wockhardt Americas Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Wockhardt Americas Inc Enalapril Product Portfolio Table 69. Wockhardt Americas Inc Recent Development Table 70. Watson Laboratories Inc Company Information Table 71. Watson Laboratories Inc Business Overview Table 72. Watson Laboratories Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Watson Laboratories Inc Enalapril Product Portfolio Table 74. Watson Laboratories Inc Recent Development Table 75. Teva Pharmaceuticals Usa Inc Company Information Table 76. Teva Pharmaceuticals Usa Inc Business Overview Table 77. Teva Pharmaceuticals Usa Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio Table 79. Teva Pharmaceuticals Usa Inc Recent Development Table 80. Teva Parenteral Medicines Inc Company Information Table 81. Teva Parenteral Medicines Inc Business Overview Table 82. Teva Parenteral Medicines Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Teva Parenteral Medicines Inc Enalapril Product Portfolio Table 84. Teva Parenteral Medicines Inc Recent Development Table 85. Taro Pharmaceutical Industries Ltd Company Information Table 86. Taro Pharmaceutical Industries Ltd Business Overview Table 87. Taro Pharmaceutical Industries Ltd Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio Table 89. Taro Pharmaceutical Industries Ltd Recent Development Table 90. Sandoz Inc Company Information Table 91. Sandoz Inc Business Overview Table 92. Sandoz Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Sandoz Inc Enalapril Product Portfolio Table 94. Sandoz Inc Recent Development Table 95. Ranbaxy Laboratories Ltd Company Information Table 96. Ranbaxy Laboratories Ltd Business Overview Table 97. Ranbaxy Laboratories Ltd Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Ranbaxy Laboratories Ltd Enalapril Product Portfolio Table 99. Ranbaxy Laboratories Ltd Recent Development Table 100. Mylan Pharmaceuticals Inc Company Information Table 101. Mylan Pharmaceuticals Inc Business Overview Table 102. Mylan Pharmaceuticals Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Mylan Pharmaceuticals Inc Enalapril Product Portfolio Table 104. Mylan Pharmaceuticals Inc Recent Development Table 105. Lek Pharmaceuticals D D Company Information Table 106. Lek Pharmaceuticals D D Business Overview Table 107. Lek Pharmaceuticals D D Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Lek Pharmaceuticals D D Enalapril Product Portfolio Table 109. Lek Pharmaceuticals D D Recent Development Table 110. Krka Dd Novo Mesto Company Information Table 111. Krka Dd Novo Mesto Business Overview Table 112. Krka Dd Novo Mesto Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Krka Dd Novo Mesto Enalapril Product Portfolio Table 114. Krka Dd Novo Mesto Recent Development Table 115. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Company Information Table 116. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview Table 117. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio Table 119. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Development Table 120. Hospira Inc Company Information Table 121. Hospira Inc Business Overview Table 122. Hospira Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Hospira Inc Enalapril Product Portfolio Table 124. Hospira Inc Recent Development Table 125. Hikma Farmaceutica (Portugal) Sa Company Information Table 126. Hikma Farmaceutica (Portugal) Sa Business Overview Table 127. Hikma Farmaceutica (Portugal) Sa Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio Table 129. Hikma Farmaceutica (Portugal) Sa Recent Development Table 130. Biovail Laboratories International Srl Company Information Table 131. Biovail Laboratories International Srl Business Overview Table 132. Biovail Laboratories International Srl Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Biovail Laboratories International Srl Enalapril Product Portfolio Table 134. Biovail Laboratories International Srl Recent Development Table 135. Bedford Laboratories Div Ben Venue Laboratories Inc Company Information Table 136. Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview Table 137. Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio Table 139. Bedford Laboratories Div Ben Venue Laboratories Inc Recent Development Table 140. Apothecon Inc Div Bristol Myers Squibb Company Information Table 141. Apothecon Inc Div Bristol Myers Squibb Business Overview Table 142. Apothecon Inc Div Bristol Myers Squibb Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio Table 144. Apothecon Inc Div Bristol Myers Squibb Recent Development Table 145. Apotex Inc Company Information Table 146. Apotex Inc Business Overview Table 147. Apotex Inc Enalapril Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Apotex Inc Enalapril Product Portfolio Table 149. Apotex Inc Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Enalapril Distributors List Table 153. Enalapril Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Enalapril Product Image Figure 2. Global Enalapril Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enalapril Sales Value (2021-2032) & (US$ Million) Figure 4. Global Enalapril Sales (2021-2032) & (K Units) Figure 5. Global Enalapril Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Enalapril Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg Image Figure 10. 2.5mg Image Figure 11. 20mg Image Figure 12. 5mg Image Figure 13. Global Enalapril Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Enalapril Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Enalapril Sales Volume Share by Type (2021-2032) Figure 16. Global Enalapril Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Enalapril Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Enalapril Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Drugs Store Image Figure 21. Global Enalapril Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Enalapril Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Enalapril Sales Volume Share by Application (2021-2032) Figure 24. Global Enalapril Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Enalapril Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Enalapril Sales Value Share by Application (2021-2032) Figure 27. Global Enalapril Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Enalapril Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Enalapril Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Enalapril Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Enalapril Sales Value (2021-2032) & (US$ Million) Figure 32. North America Enalapril Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Enalapril Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Enalapril Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Enalapril Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Enalapril Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Enalapril Sales Value (2021-2032) & (US$ Million) Figure 38. South America Enalapril Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Enalapril Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Enalapril Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Enalapril Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Enalapril Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Enalapril Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Enalapril Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Enalapril Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 2.5mg
  • 20mg
  • 5mg
Applications
  • Hospital
  • Drugs Store
Companies covered
  • Wockhardt Americas Inc
  • Watson Laboratories Inc
  • Teva Pharmaceuticals Usa Inc
  • Teva Parenteral Medicines Inc
  • Taro Pharmaceutical Industries Ltd
  • Sandoz Inc
  • Ranbaxy Laboratories Ltd
  • Mylan Pharmaceuticals Inc
  • Lek Pharmaceuticals D D
  • Krka Dd Novo Mesto
  • Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
  • Hospira Inc
  • Hikma Farmaceutica (Portugal) Sa
  • Biovail Laboratories International Srl
  • Bedford Laboratories Div Ben Venue Laboratories Inc
  • Apothecon Inc Div Bristol Myers Squibb
  • Apotex Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enalapril Sales Value (2021-2032)
  4. 1.2.2 Global Enalapril Sales Volume (2021-2032)
  5. 1.2.3 Global Enalapril Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Enalapril Market Dynamics
  1. 2.1 Enalapril Industry Trends
  2. 2.2 Enalapril Industry Drivers
  3. 2.3 Enalapril Industry Opportunities and Challenges
  4. 2.4 Enalapril Industry Restraints
3 Enalapril Market by Company
  1. 3.1 Global Enalapril Company Revenue Ranking in 2025
  2. 3.2 Global Enalapril Revenue by Company (2021-2026)
  3. 3.3 Global Enalapril Sales Volume by Company (2021-2026)
  4. 3.4 Global Enalapril Average Price by Company (2021-2026)
  5. 3.5 Global Enalapril Company Ranking (2024-2026)
  6. 3.6 Global Enalapril Company Manufacturing Base and Headquarters
  7. 3.7 Global Enalapril Company Product Type and Application
  8. 3.8 Global Enalapril Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Enalapril Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Enalapril Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Enalapril Market by Type
  1. 4.1 Enalapril Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 2.5mg
  4. 4.1.3 20mg
  5. 4.1.4 5mg
  6. 4.2 Global Enalapril Sales Volume by Type
  7. 4.2.1 Global Enalapril Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Enalapril Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Enalapril Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Enalapril Sales Value by Type
  11. 4.3.1 Global Enalapril Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Enalapril Sales Value by Type (2021-2032)
  13. 4.3.3 Global Enalapril Sales Value Share by Type (2021-2032)
5 Enalapril Market by Application
  1. 5.1 Enalapril Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.2 Global Enalapril Sales Volume by Application
  5. 5.2.1 Global Enalapril Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Enalapril Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Enalapril Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Enalapril Sales Value by Application
  9. 5.3.1 Global Enalapril Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Enalapril Sales Value by Application (2021-2032)
  11. 5.3.3 Global Enalapril Sales Value Share by Application (2021-2032)
6 Enalapril Regional Sales and Value Analysis
  1. 6.1 Global Enalapril Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enalapril Sales by Region (2021-2032)
  3. 6.2.1 Global Enalapril Sales by Region: 2021-2026
  4. 6.2.2 Global Enalapril Sales by Region (2027-2032)
  5. 6.3 Global Enalapril Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Enalapril Sales Value by Region (2021-2032)
  7. 6.4.1 Global Enalapril Sales Value by Region: 2021-2026
  8. 6.4.2 Global Enalapril Sales Value by Region (2027-2032)
  9. 6.5 Global Enalapril Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Enalapril Sales Value (2021-2032)
  12. 6.6.2 North America Enalapril Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Enalapril Sales Value (2021-2032)
  15. 6.7.2 Europe Enalapril Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Enalapril Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Enalapril Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Enalapril Sales Value (2021-2032)
  21. 6.9.2 South America Enalapril Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Enalapril Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Enalapril Sales Value Share by Country, 2025 VS 2032
7 Enalapril Country-level Sales and Value Analysis
  1. 7.1 Global Enalapril Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enalapril Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Enalapril Sales by Country (2021-2032)
  4. 7.3.1 Global Enalapril Sales by Country (2021-2026)
  5. 7.3.2 Global Enalapril Sales by Country (2027-2032)
  6. 7.4 Global Enalapril Sales Value by Country (2021-2032)
  7. 7.4.1 Global Enalapril Sales Value by Country (2021-2026)
  8. 7.4.2 Global Enalapril Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Enalapril Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Enalapril Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Enalapril Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Enalapril Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Enalapril Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Enalapril Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Enalapril Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Enalapril Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Enalapril Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Enalapril Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Enalapril Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Enalapril Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Enalapril Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Enalapril Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Enalapril Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Enalapril Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Enalapril Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Enalapril Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Enalapril Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Enalapril Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Enalapril Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Enalapril Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Enalapril Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Enalapril Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Enalapril Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Enalapril Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Enalapril Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Enalapril Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Enalapril Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Enalapril Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Enalapril Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Enalapril Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Enalapril Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Enalapril Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Enalapril Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Enalapril Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Enalapril Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Enalapril Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Enalapril Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Enalapril Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Enalapril Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Enalapril Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Enalapril Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Enalapril Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Enalapril Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Enalapril Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Enalapril Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Enalapril Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Enalapril Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Enalapril Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Enalapril Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Enalapril Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Enalapril Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Enalapril Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Enalapril Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Enalapril Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Enalapril Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Enalapril Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Enalapril Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Enalapril Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Enalapril Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Enalapril Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Enalapril Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Enalapril Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Enalapril Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Enalapril Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Enalapril Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Enalapril Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Enalapril Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Enalapril Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Enalapril Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Enalapril Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Enalapril Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Enalapril Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Enalapril Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Enalapril Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Enalapril Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Enalapril Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Enalapril Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Enalapril Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Enalapril Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Enalapril Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Enalapril Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Enalapril Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wockhardt Americas Inc
  2. 8.1.1 Wockhardt Americas Inc Company Information
  3. 8.1.2 Wockhardt Americas Inc Business Overview
  4. 8.1.3 Wockhardt Americas Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wockhardt Americas Inc Enalapril Product Portfolio
  6. 8.1.5 Wockhardt Americas Inc Recent Developments
  7. 8.2 Watson Laboratories Inc
  8. 8.2.1 Watson Laboratories Inc Company Information
  9. 8.2.2 Watson Laboratories Inc Business Overview
  10. 8.2.3 Watson Laboratories Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Watson Laboratories Inc Enalapril Product Portfolio
  12. 8.2.5 Watson Laboratories Inc Recent Developments
  13. 8.3 Teva Pharmaceuticals Usa Inc
  14. 8.3.1 Teva Pharmaceuticals Usa Inc Company Information
  15. 8.3.2 Teva Pharmaceuticals Usa Inc Business Overview
  16. 8.3.3 Teva Pharmaceuticals Usa Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio
  18. 8.3.5 Teva Pharmaceuticals Usa Inc Recent Developments
  19. 8.4 Teva Parenteral Medicines Inc
  20. 8.4.1 Teva Parenteral Medicines Inc Company Information
  21. 8.4.2 Teva Parenteral Medicines Inc Business Overview
  22. 8.4.3 Teva Parenteral Medicines Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Teva Parenteral Medicines Inc Enalapril Product Portfolio
  24. 8.4.5 Teva Parenteral Medicines Inc Recent Developments
  25. 8.5 Taro Pharmaceutical Industries Ltd
  26. 8.5.1 Taro Pharmaceutical Industries Ltd Company Information
  27. 8.5.2 Taro Pharmaceutical Industries Ltd Business Overview
  28. 8.5.3 Taro Pharmaceutical Industries Ltd Enalapril Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio
  30. 8.5.5 Taro Pharmaceutical Industries Ltd Recent Developments
  31. 8.6 Sandoz Inc
  32. 8.6.1 Sandoz Inc Company Information
  33. 8.6.2 Sandoz Inc Business Overview
  34. 8.6.3 Sandoz Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sandoz Inc Enalapril Product Portfolio
  36. 8.6.5 Sandoz Inc Recent Developments
  37. 8.7 Ranbaxy Laboratories Ltd
  38. 8.7.1 Ranbaxy Laboratories Ltd Company Information
  39. 8.7.2 Ranbaxy Laboratories Ltd Business Overview
  40. 8.7.3 Ranbaxy Laboratories Ltd Enalapril Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ranbaxy Laboratories Ltd Enalapril Product Portfolio
  42. 8.7.5 Ranbaxy Laboratories Ltd Recent Developments
  43. 8.8 Mylan Pharmaceuticals Inc
  44. 8.8.1 Mylan Pharmaceuticals Inc Company Information
  45. 8.8.2 Mylan Pharmaceuticals Inc Business Overview
  46. 8.8.3 Mylan Pharmaceuticals Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Pharmaceuticals Inc Enalapril Product Portfolio
  48. 8.8.5 Mylan Pharmaceuticals Inc Recent Developments
  49. 8.9 Lek Pharmaceuticals D D
  50. 8.9.1 Lek Pharmaceuticals D D Company Information
  51. 8.9.2 Lek Pharmaceuticals D D Business Overview
  52. 8.9.3 Lek Pharmaceuticals D D Enalapril Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lek Pharmaceuticals D D Enalapril Product Portfolio
  54. 8.9.5 Lek Pharmaceuticals D D Recent Developments
  55. 8.10 Krka Dd Novo Mesto
  56. 8.10.1 Krka Dd Novo Mesto Company Information
  57. 8.10.2 Krka Dd Novo Mesto Business Overview
  58. 8.10.3 Krka Dd Novo Mesto Enalapril Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Krka Dd Novo Mesto Enalapril Product Portfolio
  60. 8.10.5 Krka Dd Novo Mesto Recent Developments
  61. 8.11 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
  62. 8.11.1 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Company Information
  63. 8.11.2 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview
  64. 8.11.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio
  66. 8.11.5 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Developments
  67. 8.12 Hospira Inc
  68. 8.12.1 Hospira Inc Company Information
  69. 8.12.2 Hospira Inc Business Overview
  70. 8.12.3 Hospira Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hospira Inc Enalapril Product Portfolio
  72. 8.12.5 Hospira Inc Recent Developments
  73. 8.13 Hikma Farmaceutica (Portugal) Sa
  74. 8.13.1 Hikma Farmaceutica (Portugal) Sa Company Information
  75. 8.13.2 Hikma Farmaceutica (Portugal) Sa Business Overview
  76. 8.13.3 Hikma Farmaceutica (Portugal) Sa Enalapril Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio
  78. 8.13.5 Hikma Farmaceutica (Portugal) Sa Recent Developments
  79. 8.14 Biovail Laboratories International Srl
  80. 8.14.1 Biovail Laboratories International Srl Company Information
  81. 8.14.2 Biovail Laboratories International Srl Business Overview
  82. 8.14.3 Biovail Laboratories International Srl Enalapril Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biovail Laboratories International Srl Enalapril Product Portfolio
  84. 8.14.5 Biovail Laboratories International Srl Recent Developments
  85. 8.15 Bedford Laboratories Div Ben Venue Laboratories Inc
  86. 8.15.1 Bedford Laboratories Div Ben Venue Laboratories Inc Company Information
  87. 8.15.2 Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview
  88. 8.15.3 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio
  90. 8.15.5 Bedford Laboratories Div Ben Venue Laboratories Inc Recent Developments
  91. 8.16 Apothecon Inc Div Bristol Myers Squibb
  92. 8.16.1 Apothecon Inc Div Bristol Myers Squibb Company Information
  93. 8.16.2 Apothecon Inc Div Bristol Myers Squibb Business Overview
  94. 8.16.3 Apothecon Inc Div Bristol Myers Squibb Enalapril Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio
  96. 8.16.5 Apothecon Inc Div Bristol Myers Squibb Recent Developments
  97. 8.17 Apotex Inc
  98. 8.17.1 Apotex Inc Company Information
  99. 8.17.2 Apotex Inc Business Overview
  100. 8.17.3 Apotex Inc Enalapril Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Apotex Inc Enalapril Product Portfolio
  102. 8.17.5 Apotex Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enalapril Value Chain Analysis
  2. 9.1.1 Enalapril Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enalapril Sales Mode & Process
  6. 9.2 Enalapril Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enalapril Distributors
  9. 9.2.3 Enalapril Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst